{"filing":{"accession_number":"0001104659-26-104934","cik":"0001982444","ticker":"BDMDW","company_name":"Baird Medical Investment Holdings Ltd","form":"6-K","filing_date":"2026-09-03","report_date":"2026-09-03","primary_document":"tm2624742d1_6k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1982444/000110465926104934/tm2624742d1_6k.htm"},"events":[{"id":31491,"run_id":28898,"accession_number":"0001104659-26-104934","anchor_item_number":"EX-99.1","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"This is a press release announcing preliminary unaudited financial results for the six months ended June 30, 2026. The exhibit discloses revenue of $9.9 million (24.6% growth), gross profit of $8.6 million (32.0% increase), and a turnaround to net income of $13,499 from a net loss of $(11.4) million in the prior-year period. The release includes consolidated balance sheets and statements of operations, making it a discrete earnings announcement rather than a periodic financial report filing.","company_name":"Baird Medical Investment Holdings Ltd","ticker":"BDMDW","filing_date":"2026-09-03","form":"6-K","submitted_at":null,"items":[{"id":34395,"accession_number":"0001104659-26-104934","item_number":"EX-99.1","item_title":"tm2624742d1_ex99-1.htm","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This is a press release announcing preliminary unaudited financial results for the six months ended June 30, 2026. The exhibit discloses revenue of $9.9 million (24.6% growth), gross profit of $8.6 million (32.0% increase), and a turnaround to net income of $13,499 from a net loss of $(11.4) million in the prior-year period. The release includes consolidated balance sheets and statements of operations, making it a discrete earnings announcement rather than a periodic financial report filing.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-09-03T12:21:53.587427+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":34395,"accession_number":"0001104659-26-104934","item_number":"EX-99.1","item_title":"tm2624742d1_ex99-1.htm","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This is a press release announcing preliminary unaudited financial results for the six months ended June 30, 2026. The exhibit discloses revenue of $9.9 million (24.6% growth), gross profit of $8.6 million (32.0% increase), and a turnaround to net income of $13,499 from a net loss of $(11.4) million in the prior-year period. The release includes consolidated balance sheets and statements of operations, making it a discrete earnings announcement rather than a periodic financial report filing.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-09-03T12:21:53.587427+00:00","company_name":"Baird Medical Investment Holdings Ltd","ticker":"BDMDW","filing_date":"2026-09-03"}]}